1. AstraZeneca pays Sobi $95M for priority review voucher — Amgen, Allergan biosimilar of Roche's blockbuster Rituxan clears another US pivotal study — Retrophin sinks as drug “Pharma Bro” Martin Shkreli co-invented fails — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Pharma/Biotech Companies - In the News

For the discussion of current news articles in the pharma/biotech space. Please provide a link to the article, and do not cut and paste whole articles due to copyright restrictions.

Sort By:
Title
Replies Views
Last Message ↓
  1. cafead
    Replies:
    0
    Views:
    34
  2. cafead
    Replies:
    0
    Views:
    40
  3. cafead
    Replies:
    0
    Views:
    57
  4. cafead
    Replies:
    0
    Views:
    37
  5. cafead
    Replies:
    0
    Views:
    30
  6. cafead
    Replies:
    0
    Views:
    56
  7. cafead
    Replies:
    0
    Views:
    31
  8. cafead
    Replies:
    0
    Views:
    27
  9. cafead
    Replies:
    0
    Views:
    31
  10. cafead
    Replies:
    0
    Views:
    28
  11. cafead
    Replies:
    0
    Views:
    41
  12. cafead
    Replies:
    0
    Views:
    46
  13. cafead
    Replies:
    0
    Views:
    73
  14. cafead
    Replies:
    0
    Views:
    46
  15. cafead
    Replies:
    0
    Views:
    26
  16. cafead
    Replies:
    0
    Views:
    35
  17. cafead
    Replies:
    0
    Views:
    36
  18. cafead
    Replies:
    0
    Views:
    31
  19. cafead
    Replies:
    0
    Views:
    33
  20. cafead
    Replies:
    0
    Views:
    52

Thread Display Options

Loading...